Our global pages
Close- Global home
- About us
- Global services/practices
- Industries/sectors
- Our people
- Events/webinars
- News and articles
- Eversheds Sutherland (International) Press Hub
- Eversheds Sutherland (US) Press Hub
- News and articles: choose a location
- Careers
- Careers with Eversheds Sutherland
- Careers: choose a location
Eversheds Sutherland advises Medica Group on its Main Market IPO
- Global
21-03-2017
Eversheds Sutherland has advised the UK market leader in teleradiology, Medica Group plc, on its initial public offering (IPO) on the London Stock Exchange, valuing the company at £150 million.
As part of the IPO, Medica’s major selling shareholder, CBPE Capital LLP, sold the majority of its stake in Medica and retained approximately 11% in the company which it had acquired from Nuffield Health in May 2013.
The Eversheds team on the transaction was led by partners Sebastian Orton and Richard Moulton assisted by lead associate Jon Stanley. Other members of the team included Chris Brough and Hugh Wilkinson (Corporate), Danny Blum and Victoria Gree (Options) and Patrick Davis (Banking).
This information is for guidance purposes only and should not be regarded as a substitute for taking legal advice. Please refer to the full terms and conditions on our website.
- Eversheds Sutherland and Norton Rose Fulbright advise in sale of Pep Shopping Centre to Generali and ECE funds
- Chambers and Partners 2023
- Chambers and Partners 2023
- Legal Alert | Entry of members of the elected bodies in the Commercial Register - now without a criminal record extract
- Eversheds Sutherland advises Beech Tree Private Equity on its investment in Obsequio Group